All terms
Market SegmentsStrategic Landscape
Structural Heart
Transcatheter therapies for valvular and structural heart disease.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026
Definition
Structural heart refers to minimally-invasive, catheter-based therapies that repair or replace cardiac valves and close structural defects - TAVR, transcatheter mitral and tricuspid repair/replacement, left atrial appendage closure (LAAC), and PFO/ASD closure.What this means in practice
TAVR (Edwards SAPIEN, Medtronic CoreValve) transformed aortic stenosis treatment. Mitral and tricuspid programs are the next major growth drivers. Reimbursement is generally favorable through MS-DRGs and dedicated NTAPs early in launch.Primary references
3 sourcesLink health: 3 verified· last checked 2026-05-09
ACC·1AdvaMed·1MedTech Europe·1
- 1
ACC structural heart hubVerifiedACCacc.org
- 2
AdvaMed - Industry ReportsVerifiedAdvaMedadvamed.org
- 3
MedTech Europe - Facts & FiguresVerifiedMedTech Europemedtecheurope.org
Inline markers like [1] jump to the matching reference above.